These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 34783228)

  • 1. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors.
    Vianello A; Guarnieri G; Braccioni F; Lococo S; Molena B; Cecchetto A; Giraudo C; Bertagna De Marchi L; Caminati M; Senna G
    Clin Chem Lab Med; 2022 Feb; 60(3):307-316. PubMed ID: 34783228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary fibrosis in patients with COVID-19: A review].
    Chuchalin AG
    Ter Arkh; 2022 Dec; 94(11):1333-1339. PubMed ID: 37167174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients.
    Giacomelli C; Piccarducci R; Marchetti L; Romei C; Martini C
    Biochem Pharmacol; 2021 Nov; 193():114812. PubMed ID: 34687672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.
    Rumende CM
    Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis.
    Leeming DJ; Genovese F; Sand JMB; Rasmussen DGK; Christiansen C; Jenkins G; Maher TM; Vestbo J; Karsdal MA
    Respir Res; 2021 Feb; 22(1):38. PubMed ID: 33546680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling.
    Ackermann M; Kamp JC; Werlein C; Walsh CL; Stark H; Prade V; Surabattula R; Wagner WL; Disney C; Bodey AJ; Illig T; Leeming DJ; Karsdal MA; Tzankov A; Boor P; Kühnel MP; Länger FP; Verleden SE; Kvasnicka HM; Kreipe HH; Haverich A; Black SM; Walch A; Tafforeau P; Lee PD; Hoeper MM; Welte T; Seeliger B; David S; Schuppan D; Mentzer SJ; Jonigk DD
    EBioMedicine; 2022 Nov; 85():104296. PubMed ID: 36206625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequelae of COVID-19 pneumonia: Is it correct to label everything as post-COVID lung fibrosis?
    Garg M; Maralakunte M; Dhooria S
    J Postgrad Med; 2021; 67(4):224-227. PubMed ID: 34845890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Prognostically Significant Factors in COVID-19-Associated Pulmonary Fibrosis after Adaptive Lung Ventilation.
    Mirsaliyev M; Kashikova K; Zholdybayeva A; Myrzakhmetova B; Isbassarova A; Petrova N; Kozhamberdiyeva D
    Med J Islam Repub Iran; 2023; 37():118. PubMed ID: 38145181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Management of Pulmonary Fibrosis in COVID-19.
    Rumende CM; Susanto EC; Sitorus TP
    Acta Med Indones; 2021 Apr; 53(2):233-241. PubMed ID: 34251354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-COVID-19 Pulmonary Fibrosis: Facts-Challenges and Futures: A Narrative Review.
    Duong-Quy S; Vo-Pham-Minh T; Tran-Xuan Q; Huynh-Anh T; Vo-Van T; Vu-Tran-Thien Q; Nguyen-Nhu V
    Pulm Ther; 2023 Sep; 9(3):295-307. PubMed ID: 37209374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary fibrosis in patients with COVID-19: A retrospective study.
    Li F; Deng J; Song Y; Wu C; Yu B; Wang G; Li J; Zhong Y; Liang F
    Front Cell Infect Microbiol; 2022; 12():1013526. PubMed ID: 36619759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length.
    McGroder CF; Zhang D; Choudhury MA; Salvatore MM; D'Souza BM; Hoffman EA; Wei Y; Baldwin MR; Garcia CK
    Thorax; 2021 Dec; 76(12):1242-1245. PubMed ID: 33927016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.
    Morganstein T; Haidar Z; Trivlidis J; Azuelos I; Huang MJ; Eidelman DH; Baglole CJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of post-COVID lung parenchymal abnormalities during the three-month follow-up.
    Zubairi ABS; Shaikh A; Zubair SM; Ali AS; Awan S; Irfan M
    Adv Respir Med; 2021; 89(5):477-483. PubMed ID: 34612504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Fibrosis Sequelae After Recovery from COVID-19 Infection.
    Susanto AD; Triyoga PA; Isbaniah F; Fairuz A; Cendikiawan H; Zaron F; Aryanti I; Irbah SN; Hidayat M
    J Infect Dev Ctries; 2021 Mar; 15(3):360-365. PubMed ID: 33839710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of Pulmonary Fibrosis in the Context of COVID-19 and Implications for Treatment: A Narrative Review.
    Tran S; Ksajikian A; Overbey J; Li P; Li Y
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrotic lung disease: A molecular glimpse into severe Covid-19?
    Spagnolo P; Oldham JM
    EBioMedicine; 2021 Jul; 69():103470. PubMed ID: 34229279
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia.
    Yu M; Liu Y; Xu D; Zhang R; Lan L; Xu H
    Korean J Radiol; 2020 Jun; 21(6):746-755. PubMed ID: 32410413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight to Combat Post COVID-19 Mortality: Complications and their Biomarkers.
    Srivastava R; Patel PS; Dev SK; Pradhan J; Panchawat S
    Curr Mol Med; 2023; 23(8):712-725. PubMed ID: 35959906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge.
    Sechi LA; Colussi G; Bulfone L; Brosolo G; Da Porto A; Peghin M; Patruno V; Tascini C; Catena C
    Clin Res Cardiol; 2021 Jul; 110(7):1063-1072. PubMed ID: 33481096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.